LTF has been found to be down-regulated in papillary thyroid cancer [14], gastric cancer [28], and underexpressed in association with hypermethylation in prostate cancer [36, 42] and nasopharyngeal carcinoma [47], supporting a role as a tumor suppressor gene in a variety of cancer types. This evidence concerns the gene LTF and neoplasm.